4 Results for "

Src-l1 (Standard)

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Src-l1 (Standard)" in MCE Product Catalog:

Cat. No.: HY-108766R
CAS No.: 1114544-31-8
Synonyms: AP24534 hydrochloride (Standard)
Ponatinib (hydrochloride) (Standard) is the analytical standard of Ponatinib (hydrochloride). This product is intended for research and analytical applications. Ponatinib hydrochloride (AP24534 hydrochloride) is a hydrochloride of ponatinib. Ponatinib is an orally active multi-targeted kinase inhibitor with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl, PDGFRα, VEGFR2, FGFR1, and Src, respectively .
loading...
    loading...
Cat. No.: HY-101053R
CAS No.: 179248-59-0
Synonyms: Src Kinase Inhibitor 1 (Standard); Src-l1 (Standard)
Target:  

Src Reference Standards

Research Areas:  

Cancer

Src Inhibitor 1 (Standard) is the analytical standard of Src Inhibitor 1 (HY-101053). This product is intended for research and analytical applications. Src Inhibitor 1 is a potent, ATP-competitive and selective dual site Src tyrosine kinase inhibitor with IC50 values of 44 nM for Src and 88nM for Lck.
loading...
    loading...
Cat. No.: HY-12047R
CAS No.: 943319-70-8
Synonyms: AP24534 (Standard)
Research Areas:  

Cancer

Ponatinib (Standard) is the analytical standard of Ponatinib. This product is intended for research and analytical applications. Ponatinib (AP24534) is an orally active multi-targeted kinase inhibitor with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl, PDGFRα, VEGFR2, FGFR1, and Src, respectively .
loading...
    loading...
Cat. No.: HY-114421R
CAS No.: 2064175-41-1
Synonyms: dTAG-13 (Standard)
FKBP12 PROTAC dTAG-13 (Standard) is the analytical standard of FKBP12 PROTAC dTAG-13 (HY-114421). This product is intended for research and analytical applications. FKBP12 PROTAC dTAG-13 (dTAG-13) is a FKBP12 F36V PROTAC degrader and a PXR partial agonist. FKBP12 PROTAC dTAG-13 induces ubiquitination and proteasomal degradation of proteins tagged with FKBP12 F36V, without degrading wild-type FKBP12 or un-fused PXR. It weakly promotes the recruitment of SRC-1, strongly inhibits the interaction between NCoR and PXR, and upregulates the expression of CYP3A4 and other drug metabolism-related genes. FKBP12 PROTAC dTAG-13 is applicable to research related to breast cancer and leukemia .
loading...
    loading...